From: Trends in peritoneal surface malignancies: evidence from a Czech nationwide population-based study
Age by diagnosis | p rate | |||||
---|---|---|---|---|---|---|
0–49 years | 50–59 years | 60–69 years | 70–79 years | 80 years and above | ||
Peritoneal carcinomatosis total | 207 (6.6%) | 429 (13.7%) | 1048 (33.4%) | 894 (28.5%) | 559 (17.8%) | < 0.001 |
Malignant neoplasm of the colon and rectum (C18–C20) | 56 (6.5%) | 103 (12.0%) | 262 (30.4%) | 257 (29.8%) | 183 (21.3%) | < 0.001 |
Malignant neoplasm of the ovary (C56) | 26 (5.3%) | 70 (14.3%) | 157 (32.1%) | 136 (27.8%) | 100 (20.4%) | < 0.001 |
Malignant neoplasm of the stomach (C16) | 41 (10.0%) | 70 (17.2%) | 135 (33.1%) | 101 (24.8%) | 61 (15.0%) | < 0.001 |
Malignant neoplasm of the pancreas (C25) | 16 (4.2%) | 52 (13.7%) | 144 (38.0%) | 112 (29.6%) | 55 (14.5%) | < 0.001 |
Malignant neoplasm of the trachea, bronchus, and lung (C33, C34) | 9 (5.1%) | 24 (13.6%) | 73 (41.2%) | 49 (27.7%) | 22 (12.4%) | < 0.001 |
Malignant neoplasm of the gallbladder and biliary tract (C23, C24) | 4 (2.4%) | 20 (12.0%) | 53 (31.7%) | 49 (29.3%) | 41 (24.6%) | < 0.001 |
Malignant neoplasm of the liver and intrahepatic bile ducts (C22) | 4 (3.2%) | 11 (8.9%) | 38 (30.6%) | 52 (41.9%) | 19 (15.3%) | < 0.001 |
Malignant neoplasm of the uterus (C54, C55) | 4 (3.4%) | 13 (11.2%) | 44 (37.9%) | 36 (31.0%) | 19 (16.4%) | < 0.001 |
Other locality of the primary tumor | 47 (11.3%) | 66 (15.9%) | 142 (34.1%) | 102 (24.5%) | 59 (14.2%) | < 0.001 |